Biomedicines, Free Full-Text
Por um escritor misterioso
Descrição
Alpha-synuclein’s role in diseases termed “synucleinopathies”, including Parkinson’s disease, has been well-documented. However, after over 25 years of research, we still do not fully understand the alpha-synuclein protein and its role in disease. In vitro cellular models are some of the most powerful tools that researchers have at their disposal to understand protein function. Advantages include good control over experimental conditions, the possibility for high throughput, and fewer ethical issues when compared to animal models or the attainment of human samples. On the flip side, their major disadvantages are their questionable relevance and lack of a “whole-brain” environment when it comes to modeling human diseases, such as is the case of neurodegenerative disorders. Although now, with the advent of pluripotent stem cells and the ability to create minibrains in a dish, this is changing. With this review, we aim to wade through the recent alpha-synuclein literature to discuss how different cell culture setups (immortalized cell lines, primary neurons, human induced pluripotent stem cells (hiPSCs), blood–brain barrier models, and brain organoids) can help us understand aggregation pathology in Parkinson’s and other synucleinopathies.
Biomedicines, Free Full-Text
Biomedicines An Open Access Journal from MDPI
How to create three-dimensional cell culture models – faCellitate
Povyk sloužit hlavní, důležitý exosomes metastases and the miracle
Biomedicines, Free Full-Text
In-silico predicting as a tool to develop plant-based biomedicines
Physical and Mental Activity, Disease Susceptibility, and Risk of
Computer Methods and Programs in Biomedicine
Frontiers A Critical Perspective on 3D Liver Models for Drug
Biomedicines, Free Full-Text
Full article: Promising Natural Products in New Drug Design
Nonclinical pharmacokinetics and biodistribution of VSV-GP using
Biomedicines, Free Full-Text
Biomedicines, Free Full-Text
de
por adulto (o preço varia de acordo com o tamanho do grupo)